277 related articles for article (PubMed ID: 19309543)
41. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
[TBL] [Abstract][Full Text] [Related]
42. The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis.
Liu Y; Wang W; Li Y; Xiao Y; Cheng J; Jia J
Biol Pharm Bull; 2015; 38(8):1234-9. PubMed ID: 26235588
[TBL] [Abstract][Full Text] [Related]
43. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats.
Tsai SK; Hung LM; Fu YT; Cheng H; Nien MW; Liu HY; Zhang FB; Huang SS
J Vasc Surg; 2007 Aug; 46(2):346-53. PubMed ID: 17600658
[TBL] [Abstract][Full Text] [Related]
44. The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia.
Silva BC; de Miranda AS; Rodrigues FG; Silveira AL; Resende GH; Moraes MF; de Oliveira AC; Parreiras PM; Barcelos Lda S; Teixeira MM; Machado FS; Teixeira AL; Rachid MA
Curr Neurovasc Res; 2015; 12(4):398-403. PubMed ID: 26265153
[TBL] [Abstract][Full Text] [Related]
45. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
[TBL] [Abstract][Full Text] [Related]
46. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.
Zhang HT; Zhang P; Gao Y; Li CL; Wang HJ; Chen LC; Feng Y; Li RY; Li YL; Jiang CL
Mol Med Rep; 2017 Jan; 15(1):57-64. PubMed ID: 27909732
[TBL] [Abstract][Full Text] [Related]
47. Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain: down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated brain infaction and edema.
Liu Z; He D; Zhang X; Li Y; Zhu C; Dong L; Zhang X; Xing Y; Wang C; Qiao H; Chen L
Brain Res Bull; 2012 Jul; 88(4):379-84. PubMed ID: 22521762
[TBL] [Abstract][Full Text] [Related]
48. Effect of the lipoxygenase-inhibitors baicalein and zileuton on the vertebra in ovariectomized rats.
Saul D; Gleitz S; Nguyen HH; Kosinsky RL; Sehmisch S; Hoffmann DB; Wassmann M; Menger B; Komrakova M
Bone; 2017 Aug; 101():134-144. PubMed ID: 28455215
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotection of taurine through inhibition of 12/15 lipoxygenase pathway in cerebral ischemia of rats.
Zhang Z; Yu R; Cao L
Neurol Res; 2017 May; 39(5):453-458. PubMed ID: 28256152
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model.
Hu Q; Chen C; Yan J; Yang X; Shi X; Zhao J; Lei J; Yang L; Wang K; Chen L; Huang H; Han J; Zhang JH; Zhou C
Exp Neurol; 2009 Mar; 216(1):35-46. PubMed ID: 19073180
[TBL] [Abstract][Full Text] [Related]
51. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression.
Bai X; Zhang X; Chen L; Zhang J; Zhang L; Zhao X; Zhao T; Zhao Y
Neurochem Res; 2014 Aug; 39(8):1405-15. PubMed ID: 24842554
[TBL] [Abstract][Full Text] [Related]
53. Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin.
Meng Z; Cao R; Yang Z; Liu T; Wang Y; Wang X
Urology; 2013 Dec; 82(6):1452.e7-14. PubMed ID: 24295266
[TBL] [Abstract][Full Text] [Related]
54. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
[TBL] [Abstract][Full Text] [Related]
55. The protective mechanism of progesterone on blood-brain barrier in cerebral ischemia in rats.
Wang J; Jiang C; Li X; Liu C; Cheng N; Hao Y
Brain Res Bull; 2009 Aug; 79(6):426-30. PubMed ID: 19477244
[TBL] [Abstract][Full Text] [Related]
56. β-Dystroglycan cleavage by matrix metalloproteinase-2/-9 disturbs aquaporin-4 polarization and influences brain edema in acute cerebral ischemia.
Yan W; Zhao X; Chen H; Zhong D; Jin J; Qin Q; Zhang H; Ma S; Li G
Neuroscience; 2016 Jun; 326():141-157. PubMed ID: 27038751
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Hosomi N; Ban CR; Naya T; Takahashi T; Guo P; Song XY; Kohno M
J Cereb Blood Flow Metab; 2005 Aug; 25(8):959-67. PubMed ID: 15729288
[TBL] [Abstract][Full Text] [Related]
58. Carnosine Protects against Cerebral Ischemic Injury by Inhibiting Matrix-Metalloproteinases.
Kim EH; Kim ES; Shin D; Kim D; Choi S; Shin YJ; Kim KA; Noh D; Caglayan AB; Rajanikant GK; Majid A; Bae ON
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299128
[TBL] [Abstract][Full Text] [Related]
59. 2-(2-Benzofuranyl)-2-Imidazoline Mediates Neuroprotection by Regulating the Neurovascular Unit Integrity in a Rat Model of Focal Cerebral Ischemia.
Zhang Z; Zhang L; Chen J; Cao Y; Qu M; Lin X; Han Z; Ji X
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1481-1489. PubMed ID: 29398538
[TBL] [Abstract][Full Text] [Related]
60. Effects of ischemic preconditioning on blood-brain barrier permeability and MMP-9 expression of ischemic brain.
Zhang FY; Chen XC; Ren HM; Bao WM
Neurol Res; 2006 Jan; 28(1):21-4. PubMed ID: 16464358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
